Literature DB >> 26148856

The Pharmacological and Physiological Role of Multidrug-Resistant Protein 4.

Jiagen Wen1, Jianquan Luo1, Weihua Huang1, Jie Tang1, Honghao Zhou1, Wei Zhang2.   

Abstract

Multidrug-resistant protein 4 (MRP4), a member of the C subfamily of ATP-binding cassette transporters, is distributed in a variety of tissues and a number of cancers. As a drug transporter, MRP4 is responsible for the pharmacokinetics and pharmacodynamics of numerous drugs, especially antiviral drugs, antitumor drugs, and diuretics. In this regard, the functional role of MRP4 is affected by a number of factors, such as genetic mutations; tissue-specific transcriptional regulations; post-transcriptional regulations, including miRNAs and membrane internalization; and substrate competition. Unlike other C family members, MRP4 is in a pivotal position to transport cellular signaling molecules, through which it is tightly connected to the living activity and physiologic processes of cells and bodies. In the context of several cancers in which MRP4 is overexpressed, MRP4 inhibition shows striking effects against cancer progression and drug resistance. In this review, we describe the role of MRP4 more specifically in both healthy conditions and disease states, with an emphasis on its potential as a drug target.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26148856     DOI: 10.1124/jpet.115.225656

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

Review 1.  Alternative Splicing: Expanding Diversity in Major ABC and SLC Drug Transporters.

Authors:  Ji Eun Park; Gongmi Ryoo; Wooin Lee
Journal:  AAPS J       Date:  2017-10-02       Impact factor: 4.009

Review 2.  Drug-induced secretory diarrhea: A role for CFTR.

Authors:  Changsuk Moon; Weiqiang Zhang; Nambirajan Sundaram; Sunitha Yarlagadda; Vadde Sudhakar Reddy; Kavisha Arora; Michael A Helmrath; Anjaparavanda P Naren
Journal:  Pharmacol Res       Date:  2015-09-30       Impact factor: 7.658

3.  Early patterning of ABCB, ABCC, and ABCG transporters establishes unique territories of small molecule transport in embryonic mesoderm and endoderm.

Authors:  Catherine S Schrankel; Amro Hamdoun
Journal:  Dev Biol       Date:  2021-01-15       Impact factor: 3.582

Review 4.  Cyclic AMP in dendritic cells: A novel potential target for disease-modifying agents in asthma and other allergic disorders.

Authors:  Amy M Chinn; Paul A Insel
Journal:  Br J Pharmacol       Date:  2020-06-21       Impact factor: 8.739

Review 5.  Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression.

Authors:  Abdullah Mayati; Amélie Moreau; Marc Le Vée; Bruno Stieger; Claire Denizot; Yannick Parmentier; Olivier Fardel
Journal:  Int J Mol Sci       Date:  2017-04-04       Impact factor: 5.923

6.  Involvement of multidrug resistance protein 4 in the hepatocyte efflux of lamivudine and entecavir.

Authors:  Yu-Tian Liu; Wei Liu; Gang-Yan Zhu; Fu-Liang Wang; Qian Chen
Journal:  Mol Med Rep       Date:  2018-03-19       Impact factor: 2.952

7.  Discovery of novel multidrug resistance protein 4 (MRP4) inhibitors as active agents reducing resistance to anticancer drug 6-Mercaptopurine (6-MP) by structure and ligand-based virtual screening.

Authors:  Ya Chen; Xia Yuan; Zhangping Xiao; Hongwei Jin; Liangren Zhang; Zhenming Liu
Journal:  PLoS One       Date:  2018-10-15       Impact factor: 3.240

8.  HOXA13, Negatively Regulated by miR-139-5p, Decreases the Sensitivity of Gastric Cancer to 5-Fluorouracil Possibly by Targeting ABCC4.

Authors:  Zhengqian Chen; Zhiwei Qin; Lei Li; Qi Wo; Xia Chen
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

9.  A polymorphism in ABCC4 is related to efficacy of 5-FU/capecitabine-based chemotherapy in colorectal cancer patients.

Authors:  Qi Chen; Fanyi Meng; Lei Wang; Yong Mao; Huan Zhou; Dong Hua; Hongjian Zhang; Weipeng Wang
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

10.  Dexmedetomidine impairs P‑glycoprotein‑mediated efflux function in L02 cells via the adenosine 5'‑monophosphate‑activated protein kinase/nuclear factor‑κB pathway.

Authors:  Guo-Rong He; Xiao-Kun Lin; Yong-Biao Wang; Cong-De Chen
Journal:  Mol Med Rep       Date:  2018-02-02       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.